Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 201 - 210 of 230 for sinovac. (0.12 seconds)

Jiangsu Hansoh Pharma is planning a $3 billion Hong Kong...
BeiGene, a Beijing clinical-stage novel drug company,...
Luye Pharma is one of several companies vying to acquire...
HighLight Capital of Shanghai, a early-stage China...
Beijing Allcure Medical Technology raised $27 million in...
Berry Genomics, a Beijing genetic testing company, will...
Deals and Financings Shanghai Pharma may acquire part...
Deals and Financings  Suzhou's Innovent Biologics...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital